Erika L. Hubbard

机构：Ampel BioSolutions (United States) · ORCID：0000-0002-7972-2879

发表论文 18 篇 · 总被引 321 次 · h-index 7

代表论文

• Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway (2021 · Scientific Reports · 被引 162)
• Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE (2022 · Annals of the Rheumatic Diseases · 被引 46)
• Analysis of transcriptomic features reveals molecular endotypes of SLE with clinical implications (2023 · Genome Medicine · 被引 32)
• Analysis of gene expression from systemic lupus erythematosus synovium reveals myeloid cell-driven pathogenesis of lupus arthritis (2020 · Scientific Reports · 被引 25)
• Comprehensive Transcriptomic Analysis of COVID-19 Blood, Lung, and Airway (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 22)
• Validation of eight endotypes of lupus based on whole-blood RNA profiles (2025 · Lupus Science & Medicine · 被引 9)